Robert L. Hanson
AstraZeneca (United Kingdom)(GB)Northwestern University(US)East Tennessee State University(US)Instituto de Engenharia de Sistemas e Computadores Investigação e Desenvolvimento(PT)National Institutes of Health(US)Government of the United States of America(US)National Institute of Diabetes and Digestive and Kidney Diseases(US)Phoenix (United States)(US)Hutchison/MRC Research Centre(GB)AstraZeneca (Singapore)(SG)AstraZeneca (Brazil)(BR)Scottsdale Research Institute (United States)(US)
Publications by Year
Research Areas
Genetic Associations and Epidemiology, Diabetes, Cardiovascular Risks, and Lipoproteins, Birth, Development, and Health, Pancreatic function and diabetes, Diabetes and associated disorders
Most-Cited Works
- → Childhood Obesity, Other Cardiovascular Risk Factors, and Premature Death(2010)1,365 cited
- → Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships.(2000)1,280 cited
- → Adiponectin and development of type 2 diabetes in the Pima Indian population(2002)1,102 cited
- → Birth weight and non-insulin dependent diabetes: thrifty genotype, thrifty phenotype, or surviving small baby genotype?(1994)694 cited
- → Components of the “Metabolic Syndrome” and Incidence of Type 2 Diabetes(2002)588 cited
- → The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes.(2000)575 cited